Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spheroids, Cellular | 10 | 2016 | 351 | 1.490 |
Why?
|
| Toxicity Tests | 5 | 2017 | 121 | 1.080 |
Why?
|
| Xenobiotics | 4 | 2017 | 73 | 0.760 |
Why?
|
| Cytochrome P-450 CYP1A1 | 3 | 2013 | 91 | 0.520 |
Why?
|
| Liver | 8 | 2017 | 7474 | 0.450 |
Why?
|
| Oncorhynchus mykiss | 4 | 2017 | 24 | 0.440 |
Why?
|
| Kidney Tubules | 1 | 2013 | 488 | 0.380 |
Why?
|
| Hepatocytes | 6 | 2012 | 1211 | 0.360 |
Why?
|
| Galactose | 3 | 2013 | 306 | 0.350 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2017 | 1375 | 0.290 |
Why?
|
| Energy Metabolism | 3 | 2012 | 2899 | 0.240 |
Why?
|
| Glucose | 6 | 2013 | 4397 | 0.230 |
Why?
|
| Albumins | 3 | 2012 | 569 | 0.230 |
Why?
|
| Water Pollutants, Chemical | 2 | 2017 | 311 | 0.230 |
Why?
|
| Pyruvic Acid | 3 | 2013 | 200 | 0.220 |
Why?
|
| Rats, Wistar | 3 | 2013 | 1901 | 0.180 |
Why?
|
| Rats | 10 | 2013 | 24260 | 0.170 |
Why?
|
| Galactosamine | 3 | 2003 | 30 | 0.170 |
Why?
|
| Nitric Oxide | 3 | 2009 | 2132 | 0.170 |
Why?
|
| Cryopreservation | 1 | 2003 | 670 | 0.170 |
Why?
|
| Ecotoxicology | 2 | 2017 | 7 | 0.150 |
Why?
|
| Diclofenac | 3 | 2017 | 71 | 0.150 |
Why?
|
| Opioid Peptides | 2 | 2009 | 42 | 0.140 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2016 | 165 | 0.140 |
Why?
|
| Propranolol | 3 | 2017 | 502 | 0.130 |
Why?
|
| L-Lactate Dehydrogenase | 3 | 2012 | 424 | 0.130 |
Why?
|
| Copper | 1 | 2017 | 366 | 0.120 |
Why?
|
| Culture Techniques | 2 | 2003 | 554 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2003 | 8301 | 0.110 |
Why?
|
| Chick Embryo | 2 | 2006 | 982 | 0.110 |
Why?
|
| Blood-Brain Barrier | 3 | 2004 | 1017 | 0.110 |
Why?
|
| Oximetry | 1 | 2016 | 471 | 0.110 |
Why?
|
| Biotransformation | 2 | 2017 | 168 | 0.110 |
Why?
|
| Cell Survival | 5 | 2012 | 5882 | 0.100 |
Why?
|
| Glutathione | 2 | 2003 | 589 | 0.100 |
Why?
|
| Cell Movement | 1 | 2003 | 5217 | 0.100 |
Why?
|
| Acetaminophen | 2 | 2003 | 545 | 0.080 |
Why?
|
| Animals | 17 | 2017 | 168757 | 0.080 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2012 | 964 | 0.080 |
Why?
|
| Brain | 2 | 2006 | 26385 | 0.080 |
Why?
|
| Cell Death | 2 | 2002 | 1706 | 0.070 |
Why?
|
| Cell Culture Techniques | 2 | 2012 | 1678 | 0.070 |
Why?
|
| Ultrasonics | 1 | 2007 | 212 | 0.070 |
Why?
|
| Endothelium, Vascular | 3 | 2004 | 4456 | 0.070 |
Why?
|
| Ovum | 1 | 2006 | 189 | 0.070 |
Why?
|
| T-Lymphocytes | 4 | 2009 | 10180 | 0.060 |
Why?
|
| Peroxynitrous Acid | 1 | 2004 | 41 | 0.060 |
Why?
|
| Kinetics | 3 | 2017 | 6473 | 0.060 |
Why?
|
| Oxygen | 1 | 2016 | 4189 | 0.060 |
Why?
|
| Electrodes | 1 | 2006 | 619 | 0.060 |
Why?
|
| Organ Culture Techniques | 1 | 2006 | 813 | 0.060 |
Why?
|
| Acetylcholinesterase | 1 | 2003 | 153 | 0.060 |
Why?
|
| Galactose Dehydrogenases | 1 | 2002 | 1 | 0.060 |
Why?
|
| Endpoint Determination | 1 | 2006 | 601 | 0.060 |
Why?
|
| Electrophysiology | 1 | 2006 | 1308 | 0.060 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2003 | 134 | 0.060 |
Why?
|
| Embryo, Nonmammalian | 1 | 2006 | 895 | 0.050 |
Why?
|
| Toxicology | 1 | 2002 | 106 | 0.050 |
Why?
|
| Cell Size | 1 | 2003 | 643 | 0.050 |
Why?
|
| Urea | 1 | 2003 | 450 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2002 | 537 | 0.050 |
Why?
|
| Embryonic Development | 1 | 2006 | 711 | 0.050 |
Why?
|
| Culture Media | 1 | 2003 | 908 | 0.050 |
Why?
|
| Lactic Acid | 1 | 2006 | 1133 | 0.050 |
Why?
|
| NAD | 1 | 2002 | 593 | 0.040 |
Why?
|
| Cell Division | 1 | 2006 | 4568 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2002 | 6314 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2002 | 2557 | 0.040 |
Why?
|
| Amino Acids | 1 | 2003 | 1736 | 0.040 |
Why?
|
| Phenylbutazone | 1 | 2017 | 8 | 0.040 |
Why?
|
| Atenolol | 1 | 2017 | 100 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2006 | 10943 | 0.040 |
Why?
|
| Metoprolol | 1 | 2017 | 93 | 0.040 |
Why?
|
| Diazepam | 1 | 2017 | 205 | 0.030 |
Why?
|
| Carbamazepine | 1 | 2017 | 229 | 0.030 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2007 | 2214 | 0.030 |
Why?
|
| Cell Line | 3 | 2017 | 15997 | 0.030 |
Why?
|
| Cricetulus | 2 | 2009 | 816 | 0.030 |
Why?
|
| Male | 7 | 2013 | 350118 | 0.030 |
Why?
|
| CHO Cells | 2 | 2009 | 1406 | 0.030 |
Why?
|
| Time Factors | 2 | 2013 | 40075 | 0.030 |
Why?
|
| Cricetinae | 2 | 2009 | 2472 | 0.030 |
Why?
|
| Umbilical Veins | 2 | 2004 | 433 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2002 | 3760 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2007 | 4253 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2017 | 1157 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2006 | 19229 | 0.020 |
Why?
|
| Models, Animal | 1 | 2017 | 2171 | 0.020 |
Why?
|
| Models, Biological | 2 | 2004 | 9583 | 0.020 |
Why?
|
| Proteins | 1 | 2003 | 6103 | 0.020 |
Why?
|
| Prostaglandins | 1 | 2009 | 405 | 0.020 |
Why?
|
| Perfusion | 1 | 2012 | 1360 | 0.020 |
Why?
|
| Cell Aggregation | 1 | 2007 | 244 | 0.020 |
Why?
|
| Gels | 1 | 2007 | 427 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2009 | 5974 | 0.020 |
Why?
|
| Environmental Monitoring | 1 | 2012 | 1414 | 0.020 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2007 | 319 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 2699 | 0.020 |
Why?
|
| Metalloporphyrins | 1 | 2004 | 41 | 0.020 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 59 | 0.010 |
Why?
|
| Thymidine | 1 | 2004 | 310 | 0.010 |
Why?
|
| Prostaglandin D2 | 1 | 2004 | 122 | 0.010 |
Why?
|
| Tritium | 1 | 2004 | 745 | 0.010 |
Why?
|
| Receptors, Opioid | 1 | 2004 | 155 | 0.010 |
Why?
|
| Indomethacin | 1 | 2004 | 332 | 0.010 |
Why?
|
| Phytohemagglutinins | 1 | 2002 | 170 | 0.010 |
Why?
|
| Concanavalin A | 1 | 2002 | 191 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2004 | 573 | 0.010 |
Why?
|
| Cell Proliferation | 2 | 2009 | 10481 | 0.010 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2004 | 371 | 0.010 |
Why?
|
| Pregnancy | 1 | 2003 | 29144 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2004 | 4420 | 0.010 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2004 | 906 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2004 | 595 | 0.010 |
Why?
|
| Dinoprostone | 1 | 2004 | 600 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2002 | 743 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 2004 | 927 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2009 | 2007 | 0.010 |
Why?
|
| Lectins, C-Type | 1 | 2004 | 588 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2009 | 3206 | 0.010 |
Why?
|
| Actins | 1 | 2007 | 2121 | 0.010 |
Why?
|
| Female | 3 | 2017 | 380194 | 0.010 |
Why?
|
| Principal Component Analysis | 1 | 2002 | 940 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2004 | 1460 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2002 | 2031 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2009 | 5524 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2004 | 1836 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 3870 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2004 | 2077 | 0.010 |
Why?
|
| Transfection | 1 | 2004 | 5892 | 0.010 |
Why?
|
| Cell Communication | 1 | 2002 | 1621 | 0.010 |
Why?
|
| Triglycerides | 1 | 2002 | 2454 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2004 | 3200 | 0.010 |
Why?
|
| Cholesterol | 1 | 2002 | 2917 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2004 | 4026 | 0.010 |
Why?
|
| Humans | 7 | 2009 | 744343 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2004 | 4386 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 16689 | 0.010 |
Why?
|
| Glioma | 1 | 2002 | 3401 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 2004 | 12072 | 0.000 |
Why?
|
| Adult | 1 | 2004 | 214055 | 0.000 |
Why?
|
Concepts
(141)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_